JD
At a glance
Registered since
2024
Senate LDA system
Clients
5
last 3 years
Filings
16
8 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Senior Legislative Assistant/ Legislative Assistant
Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission
Disclosed on LD-2 filings
Senior Legislative Assistant / Legislative Assistant
Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst / Campaign Finance Analyst, Federal election Commission
Disclosed on LD-2 filings
Career
TS
Specific issues
Meetings / interactions with HHS and congressional offices - to increase federal government awareness of client's groundbreaking medical research and in preparation for grant proposal(s)
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Discussions with / outreach to Congressional offices and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing resources devoted to the development of improved addiction medicines.
Discussions with / outreach to Congressional offices and prep for mtgs with VA officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing resources devoted to the development of improved addiction medicines.
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
Clients
Filing history
1DAY SOONER ACTION PROJECT
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH
KARDIOGENICS, INC.
SPEAR HUMAN PERFORMANCE, INC.
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
SPEAR HUMAN PERFORMANCE, INC.
1DAY SOONER ACTION PROJECT
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH
1DAY SOONER ACTION PROJECT
KARDIOGENICS, INC.
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER